Trodelvy 180 Sacituzumab – Trastuzumab Injections

Trodelvy (sacituzumab govitecan) offers targeted therapy for certain triple-negative breast cancer patients and HR+/HER2- metastatic breast cancer (mBC). The Trodelvy injection cost in India is not fixed, as it is not approved in India by the CDSCO (Central Drugs Standard Control Organization). But, Indian patients can access this therapeutic drug through legal import mechanisms called the Named Patient Program. Under these provisions—imposed particularly for unapproved or unavailable life-saving medicines—patients or treating physicians may request Trodelvy under their name, using a valid medical preion and applicable import permits (Form 12A/12B). Indian Pharma Network (IPN) assists in navigating these complex regulatory pathways. We coordinate documentation, import permissions, and logistics to help hospitals, clinicians, and patients legally obtain Trodelvy 180 mg injection from trusted sources. Kindly call/WhatsApp: + 91-9310090915 us today to access Trodelvy in India.